John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 44,326 shares at $9.10 ($403K) on 2024-03-25, disclosed to the SEC on 2024-03-26.
Open-market sale of $403k SERA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.10 | 22,163 | $202K | 50.0% |
| 2 | $9.10 | 22,163 | $202K | 50.0% |
| Total | $9.10 avg | 44,326 | $403K | 100% |
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |